Your session is about to expire
← Back to Search
SIESTA Rehab Education for Stroke Recovery
N/A
Waitlist Available
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights
Study Summary
This trial will test whether the SIESTA-Rehab intervention leads to better sleep and improved recovery for stroke patients during acute rehabilitation.
Who is the study for?
This trial is for adults over 18 who've had a stroke and are admitted to the Shirley Ryan AbilityLab. They must be able to consent, follow study procedures, and have medical clearance. It's not for those with serious heart conditions, neurological diseases like MS or Alzheimer's, pregnant/nursing women, people with skin allergies/open wounds, or users of certain cardiac devices.Check my eligibility
What is being tested?
The SIESTA program aims to improve sleep during acute stroke rehabilitation by educating nurses on minimizing disruptions and using a protocol called ApneaLink to screen and treat sleep-disordered breathing if it occurs.See study design
What are the potential side effects?
Since this trial focuses on education and screening protocols rather than medications or invasive treatments, side effects may be minimal but could include discomfort from wearing the ApneaLink device for sleep monitoring.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in total sleep time as measured by Actigraphy
Karolinska Sleep Diary
Modified Potential Disruptions of Hospital Sleep Questionnaire (PDHSQ)
+1 moreSecondary outcome measures
10-Meter Walk Test (10MWT)
6-Minute Walk Test with VO2 analysis (6MWT)
Apnea Hypopnea Index (AHI)
+13 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SIESTA RehabExperimental Treatment2 Interventions
Stroke floor on which nurses will be receiving training (SIESTA Rehab Education) on how to minimize nighttime disruptions and batching overnight tasks to preserve sleep for patients hospitalized on that floor. Stroke patients admitted to the SIESTA Rehab Unit will be screening for sleep disordered breathing using ApneaLink.
Patients hospitalized on this unit will be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.
Group II: Control UnitActive Control1 Intervention
Patients on this unit will receive usual care for stroke patients as outlined by SRALab. including routine nursing care without any intervention to promote sleep like SIESTA and routing sleep disorders screenings based on clinician judgement.
Patients hospitalized on this unit will also be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,012 Previous Clinical Trials
733,670 Total Patients Enrolled
10 Trials studying Stroke
5,250 Patients Enrolled for Stroke
Shirley Ryan AbilityLabOTHER
199 Previous Clinical Trials
16,719 Total Patients Enrolled
71 Trials studying Stroke
8,025 Patients Enrolled for Stroke
Northwestern UniversityOTHER
1,601 Previous Clinical Trials
915,264 Total Patients Enrolled
31 Trials studying Stroke
24,835 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have serious heart conditions or diseases like MS, Alzheimer's, or Parkinson's.You are currently staying at the Shirley Ryan AbilityLab due to a stroke.I am 18 years old or older.You have a powered heart monitoring or support device implanted, like a pacemaker or defibrillator.I have skin allergies, irritations, or open wounds.
Research Study Groups:
This trial has the following groups:- Group 1: SIESTA Rehab
- Group 2: Control Unit
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Stroke Patient Testimony for trial: Trial Name: NCT04254484 — N/A
Share this study with friends
Copy Link
Messenger